Is there an Atovaquone/Proguanil (Malarone) shortage in 2026? Get the latest supply update, what's causing availability issues, and what patients can do.
If you've been told your pharmacy can't fill your Atovaquone/Proguanil prescription, you may be wondering: is there a shortage? Here's what we know about the supply situation in 2026 and what you can do to make sure you're protected before your trip.
As of March 2026, Atovaquone/Proguanil is not on the FDA's official drug shortage list. The drug has not experienced a significant nationwide shortage in recent years. Multiple generic manufacturers — including Mylan (Viatris), Teva, Cipla, Sun Pharma, Aurobindo, Lupin, and Glenmark — continue to produce the medication, which helps maintain a stable supply.
However, "not on the shortage list" doesn't mean it's always easy to find. Many patients report difficulty locating Atovaquone/Proguanil at their local pharmacies, especially during peak travel seasons. This is less about a true shortage and more about how pharmacies stock travel medications.
Atovaquone/Proguanil demand follows travel patterns. Pharmacies see spikes in prescriptions during:
During these periods, pharmacies that don't normally stock Atovaquone/Proguanil may run out quickly once a few prescriptions come in. This creates the perception of a shortage even when national supply is adequate.
Most retail pharmacies use "just-in-time" inventory systems, meaning they order medications based on current prescriptions rather than keeping large stockpiles. For a travel medication like Atovaquone/Proguanil, this means many pharmacies simply don't have it on the shelf — they need to order it when a prescription comes in.
For a deeper look at why this happens, read our article on why Atovaquone/Proguanil is so hard to find.
International travel has continued to grow through 2025 and into 2026, especially to malaria-endemic regions in sub-Saharan Africa and Southeast Asia. More travelers mean more prescriptions, which can strain local supplies even when national inventories are stable.
Brand-name Malarone (manufactured by GSK) is generally available but far more expensive than generics — often $200-$350 for 30 tablets vs. $43-$70 for generic versions with a coupon. Some pharmacies may not stock the brand at all since most prescriptions are filled with generics. If your doctor wrote the prescription for "Malarone" specifically, ask if a generic substitution is acceptable.
Use MedFinder to find pharmacies near you that have Atovaquone/Proguanil in stock right now. This is the fastest way to avoid calling around. For a complete walkthrough, see our guide to finding Atovaquone/Proguanil in stock.
Don't wait until the last minute. Fill your prescription at least 2-3 weeks before your trip. If the pharmacy needs to order it, this gives them time. Remember, you only need to start taking Atovaquone/Proguanil 1-2 days before entering a malaria area.
If your pharmacy doesn't have it in stock, ask them to order it. Most wholesalers can deliver within 1-3 business days. Be specific: ask for generic Atovaquone/Proguanil 250/100 mg tablets.
Large chain pharmacies (CVS, Walgreens, Walmart, Costco) and those near international airports are more likely to stock Atovaquone/Proguanil. Specialty travel medicine clinics may also dispense it directly.
If Atovaquone/Proguanil is genuinely unavailable in your area, effective alternatives exist. Doxycycline is the most widely available and affordable option at $10-$30 per course. Read our full comparison of alternatives to Atovaquone/Proguanil.
Discount coupons from GoodRx, SingleCare, and other services can make Atovaquone/Proguanil significantly more affordable (as low as ~$43 for 30 tablets) and often show you which pharmacies have it in stock. See our complete savings guide.
Here are reliable sources to monitor:
If you're a healthcare provider dealing with patient concerns about Atovaquone/Proguanil availability, see our dedicated provider guide: Atovaquone/Proguanil shortage: What providers need to know in 2026.
There is no formal FDA shortage of Atovaquone/Proguanil in 2026, but localized availability issues — driven by seasonal demand and pharmacy stocking patterns — can make it feel like one. The key is to plan ahead, use tools like MedFinder to locate stock, and have a backup plan with an alternative antimalarial if needed. Don't let a stock issue derail your travel health planning.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
